While the trial found benefits of yoga increased over time, the intervention of 1 class per week was less than what is typical for people with a regular practice.
Adding the practice of hatha yoga to medication may not alleviate symptoms of depression right away, but the benefits may accumulate over time, according to the largest study of yoga for depression to date.
Results from the randomized controlled trial, reported in the journal Psychological Medicine, compared the effects of a weekly yoga class with a health education class for 2 groups of patients taking antidepressants for symptoms. A blind rater assessed depression symptoms after 10 weeks, using the Quick Inventory of Depression Symptomatology, or QIDS.
Other outcomes included depression symptoms during the intervention and at follow-up periods, as well as social functioning, pain, and physical functioning.
The yoga intervention in the trial is less than what is typical for those with a regular practice. While there is no set amount for a person who is starting yoga, 3 sessions per week is recommended to acclimate the body to the poses and breathing of hatha yoga. This is the form commonly practiced in the United States.
At 10 weeks, the researchers did not find a statistically significant difference between the 2 groups. However, over the length of the interview and follow-up period, those who took part in the yoga intervention had lower levels of depression than the education group—at 6 months, 51% of the those who took yoga had a response, which was defined as more than a 50% reduction in symptoms, compared with 31% of the education group. Those in the yoga group also had significantly better social functioning and overall health.
“The purpose of this study was to examine whether hatha yoga is effective for treating depression when used in addition to antidepressant medication,” Lisa Uebelacker, PhD, a research psychologist at Butler Hospital and an associate professor at Brown University, said in statement. “We found that yoga did indeed have an impact on depression symptoms.”
More and more studies are being done about yoga’s effects on health. Clinical trials are examining its effects on preventing diabetes and managing glycemic control in those who have the disease, as well as helping seniors maintain good balance as they age. Yoga is not typically covered by health plans, but some employers have experimented with offering it as part of wellness programs.
Reference
Uebelacker LA, Tremont G, Gillette LT, et al. Adjunctive yoga v. health education for persistent major depression: a randomized controlled trial [published online April 6, 2017]. Psych Med. 2017; doi: https://doi.org/10.1017/S0033291717000575.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More